Cytokine pattern in the cerebrospinal fluid from patients with GBS and CIDP

Journal of the Neurological Sciences

Volumn 147, Issue 1, 1997, Pages 93-95

  Sivieri, S ^a   Ferrarini, A M ^a   Lolli, F ^b   Mata S ^b   Pinto, F ^b   Tavolato, B ^a   Gallo, P ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cerebrospinal fluid; Cytokines; Guillain Barre syndrome; Macrophages

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MACROPHAGE; MALE; POLYNEUROPATHY; PRIORITY JOURNAL;

CYTOKINES; DEMYELINATING DISEASES; HUMANS; POLYRADICULONEUROPATHY;

EID: 0031579673     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(96)00319-X     Document Type: Article

References (13)

1. American Academy of Neurology Task Force (1991) Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy. Neurology. 41: 617-618.
2. Albers, J.W. and Kelly, J.J. (1989) Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve, 12: 435-451.
3. Asbury, A.K., Arnason, B.G.W., Karp, H.R. and McFarlin, D.F. (1978) Criteria for the diagnosis of Giullain-Barré syndrome. Ann. Neurol., 3: 565-566.
4. Gallo, P., Pagni, S., Giometto, B., Piccinno, M.G., Bozza, F., Argentiero, V. and Tavolato, B. (1990) Macrophage-colony stimulating factor (M-CSF) in the cerebrospinal fluid. J. Neuroimmunol., 29: 105-112.
5. Hartung, H.-P., Hughes, R.A.C., Taylor, W.A., Heininger, K., Reiners, K. and Toyka, K.V. (1990) T cell activation in Guiallin-Barré syndrome and in MS: elevated serum levels of IL-2 receptors. Neurology, 40: 215-218.
6. Hartung, H.-P., Reiners, K., Schmidt, B., Stoll, G. and Toyka, K.V. (1991) Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopatic demyelinating polyradicoloneuropathy: comparison with other neurological diseases of presumed immunopathogenesis. Ann. Neurol., 30: 48-53.
7. Hartung, H.-P. Reiners, K., Mechels, M., Hughes, R.A.C., Heidenreich, F., Zielasek, J., Enders, J. and Toyka, K.V. (1994) Serum levels of soluble E-selectin (ELAM-1) in immune mediated neuropathies. Neurology, 44: 1153-1158.
8. Hauser, S.L., Doolittle, T.H., Lincoln, R., Brown, R.H. and Dinarello, C.A. (1990) Cytokine accumulation in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology, 40: 1735-1739.
9. Maimone, D., Annunziata, P., Simone, I.L., Livrea, P. and Guazzi, G.C. (1993) Interleukin-6 in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J. Neuroimmunol., 47: 55-62.
10. Sharief, M.K., McLean, B. and Thompson, E.J. (1993) Elevated serum levels of tumor necrosis factor-α in Guillain-Barré syndrome. Ann. Neurol., 33: 591-596.
11. Tavolato, B. and Gallo, P. (1994) Intrathecal cytokine synthesis in inflammatory and demyelinating diseases of the central nervous system. In: S. Salvati (Ed.), A Multidisciplinary Approach to Myelin Diseases, II. Plenum Press, New York, pp. 167-175.
12. Tsukada, N., Miyagi, K., Matsuda, M., Yanagisawa, N. and Yone, K. (1991) Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis, J. Neurol. Sci., 102: 230-234.
13. Weller, M., Stevens, A., Sommer, N., Melms, A., Dichgans, J. and Wietholter, N. (1991) Comparative analysis of cytokine pattern in immunological and oncological neurological disorders. J. Neurol. Sci., 104: 215-221.